Literature DB >> 8163674

Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease.

W M Holleran1, E I Ginns, G K Menon, J U Grundmann, M Fartasch, C E McKinney, P M Elias, E Sidransky.   

Abstract

Hydrolysis of glucosylceramide by beta-glucocerebrosidase results in ceramide, a critical component of the intercellular lamellae that mediate the epidermal permeability barrier. A subset of type 2 Gaucher patients displays ichthyosiform skin abnormalities, as do transgenic Gaucher mice homozygous for a null allele. To investigate the relationship between glucocerebrosidase deficiency and epidermal permeability barrier function, we compared the stratum corneum (SC) ultrastructure, lipid content, and barrier function of Gaucher mice to carrier and normal mice, and to hairless mice treated topically with bromoconduritol B epoxide (BrCBE), an irreversible inhibitor of glucocerebrosidase. Both Gaucher mice and BrCBE-treated mice revealed abnormal, incompletely processed, lamellar body-derived sheets throughout the SC interstices, while transgenic carrier mice displayed normal bilayers. The SC of a severely affected type 2 Gaucher's disease infant revealed similarly abnormal ultrastructure. Furthermore, the Gaucher mice demonstrated markedly elevated transepidermal water loss (4.2 +/- 0.6 vs < 0.10 g/m2 per h). The electron-dense tracer, colloidal lanthanum, percolated between the incompletely processed lamellar body-derived sheets in the SC interstices of Gaucher mice only, demonstrating altered permeability barrier function. Gaucher and BrCBE-treated mice showed < 1% and < 5% of normal epidermal glucocerebrosidase activity, respectively, and the epidermis/SC of Gaucher mice demonstrated elevated glucosylceramide (5- to 10-fold), with diminished ceramide content. Thus, the skin changes observed in Gaucher mice and infants may result from the formation of incompetent intercellular lamellar bilayers due to a decreased hydrolysis of glucosylceramide to ceramide. Glucocerebrosidase therefore appears necessary for the generation of membranes of sufficient functional competence for epidermal barrier function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163674      PMCID: PMC294236          DOI: 10.1172/JCI117160

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  Collodion babies with Gaucher's disease.

Authors:  K Lui; C Commens; R Choong; R Jaworski
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

Review 2.  The physical properties of glycolipids.

Authors:  W Curatolo
Journal:  Biochim Biophys Acta       Date:  1987-06-24

3.  Ichthyosis and neutral lipid storage disease.

Authors:  M L Williams; T K Koch; J J O'Donnell; P H Frost; L B Epstein; W S Grizzard; C J Epstein
Journal:  Am J Med Genet       Date:  1985-04

4.  Cytochemical and biochemical localization of lipase and sphingomyelinase activity in mammalian epidermis.

Authors:  G K Menon; S Grayson; P M Elias
Journal:  J Invest Dermatol       Date:  1986-05       Impact factor: 8.551

5.  Variations in lipids in different layers of porcine epidermis.

Authors:  P Cox; C A Squier
Journal:  J Invest Dermatol       Date:  1986-12       Impact factor: 8.551

6.  The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes.

Authors:  E Beutler; W Kuhl
Journal:  J Lab Clin Med       Date:  1970-11

7.  Studies on contact sensitivity to chromium in the guinea pig. The role of valence in the formation of the antigenic determinant.

Authors:  U Siegenthaler; A Laine; L Polak
Journal:  J Invest Dermatol       Date:  1983-01       Impact factor: 8.551

8.  Human epidermal lipids: characterization and modulations during differentiation.

Authors:  M A Lampe; M L Williams; P M Elias
Journal:  J Lipid Res       Date:  1983-02       Impact factor: 5.922

9.  Cutaneous manifestations of Gaucher disease.

Authors:  J Goldblatt; P Beighton
Journal:  Br J Dermatol       Date:  1984-09       Impact factor: 9.302

10.  Characterization of cellular lipids in doxorubicin-sensitive and -resistant P388 mouse leukemia cells.

Authors:  W M Holleran; M W DeGregorio; R Ganapathi; J R Wilbur; B A Macher
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

View more
  69 in total

1.  A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma.

Authors:  Eli Sprecher; Akemi Ishida-Yamamoto; Mordechai Mizrahi-Koren; Debora Rapaport; Dorit Goldsher; Margarita Indelman; Orit Topaz; Ilana Chefetz; Hanni Keren; Timothy J O'brien; Dani Bercovich; Stavit Shalev; Dan Geiger; Reuven Bergman; Mia Horowitz; Hanna Mandel
Journal:  Am J Hum Genet       Date:  2005-06-20       Impact factor: 11.025

2.  Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death.

Authors:  Vidyullatha Vasireddy; Yoshikazu Uchida; Norman Salem; Soo Yeon Kim; Md Nawajesh Ali Mandal; Geereddy Bhanuprakash Reddy; Ravi Bodepudi; Nathan L Alderson; Johnie C Brown; Hiroko Hama; Andrzej Dlugosz; Peter M Elias; Walter M Holleran; Radha Ayyagari
Journal:  Hum Mol Genet       Date:  2007-01-05       Impact factor: 6.150

3.  Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation.

Authors:  Yuko Oda; Yoshikazu Uchida; Sam Moradian; Debra Crumrine; Peter M Elias; Daniel D Bikle
Journal:  J Invest Dermatol       Date:  2008-12-04       Impact factor: 8.551

4.  The clinical, molecular, and pathological characterisation of a family with two cases of lethal perinatal type 2 Gaucher disease.

Authors:  E Sidransky; N Tayebi; B K Stubblefield; W Eliason; A Klineburgess; G P Pizzolato; J N Cox; J Porta; A Bottani; C D DeLozier-Blanchet
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

Review 5.  The clinical management of Type 2 Gaucher disease.

Authors:  Karin Weiss; Ashley Gonzalez; Grisel Lopez; Leah Pedoeim; Catherine Groden; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2014-11-14       Impact factor: 4.797

6.  Alteration of the 4-sphingenine scaffolds of ceramides in keratinocyte-specific Arnt-deficient mice affects skin barrier function.

Authors:  Satoshi Takagi; Hiromasa Tojo; Shuhei Tomita; Shigetoshi Sano; Satoshi Itami; Mariko Hara; Shintaro Inoue; Kyoji Horie; Gen Kondoh; Ko Hosokawa; Frank J Gonzalez; Junji Takeda
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

7.  ABCA12 maintains the epidermal lipid permeability barrier by facilitating formation of ceramide linoleic esters.

Authors:  Ying Zuo; Debbie Z Zhuang; Rong Han; Giorgis Isaac; Jennifer J Tobin; Mary McKee; Ruth Welti; Janice L Brissette; Michael L Fitzgerald; Mason W Freeman
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

8.  Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2.

Authors:  Marianne Demerjian; Jean-Pierre Hachem; Erwin Tschachler; Geertrui Denecker; Wim Declercq; Peter Vandenabeele; Theodora Mauro; Melanie Hupe; Debra Crumrine; Truus Roelandt; Evi Houben; Peter M Elias; Kenneth R Feingold
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

9.  Murine models of acute neuronopathic Gaucher disease.

Authors:  Ida Berglin Enquist; Christophe Lo Bianco; Andreas Ooka; Eva Nilsson; Jan-Eric Månsson; Mats Ehinger; Johan Richter; Roscoe O Brady; Deniz Kirik; Stefan Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-22       Impact factor: 11.205

10.  Abnormal nonstoring capillary endothelium: a novel feature of Gaucher disease. Ultrastructural study of dermal capillaries.

Authors:  Helena Hůlková; Helena Poupetová; Klaus Harzer; Pramod Mistry; Johannes M F G Aerts; Milan Elleder
Journal:  J Inherit Metab Dis       Date:  2010-01-05       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.